Pliant Therapeutics Inc. logo

Pliant Therapeutics Inc.

PLRX | NASDAQ
Chart Builder DCF Calculator
$0.85
-$0.01 (-1.04%)
Nov 2, 2026, 12:34 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
Cash & Equivalents
45.45M 71.19M 63.23M 33.69M 51.67M 50.88M
Short-Term Investments
145.5M 284.54M 431.01M 297.5M 148.93M 226.01M
Long-Term Investments
n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
3.77M 1.92M 1.87M 394K 838K 451K
Receivables
823K 2.3M 3M 3.14M 2.47M 9.36M
Inventory
n/a n/a n/a n/a n/a n/a
Other Current Assets
1.13M 163K 1.27M 173K 156K n/a
Total Current Assets
196.45M 362.26M 505.5M 340.31M 209.44M 290.75M
Property-Plant & Equipment
25.01M 32.77M 4.78M 9.91M 10.94M 4.32M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
28.78M 34.69M 6.65M 10.3M 11.77M 4.77M
Total Assets
225.23M 396.95M 512.15M 350.61M 221.22M 295.53M
Account Payables
480K 5.96M 4.53M 1.58M 2.97M 2.02M
Deferred Revenue
n/a n/a n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a n/a n/a
Other Current Liabilities
8.3M 11.15M 9.04M 7.2M 5.22M 4.63M
Total Current Liabilities
16.37M 33.22M 28.52M 23.91M 16.83M 11.6M
Long-Term Debt
n/a 30.21M 10.05M 9.93M n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a n/a 866K
Total Long-Term Liabilities
27.66M 59.65M 10.05M 13.36M 5.33M 866K
Total Liabilities
44.02M 92.87M 38.58M 37.27M 22.16M 12.47M
Total Debt
29.11M 60.19M 11.37M 15.82M 7.19M n/a
Book Value
181.21M 304.08M 473.58M 313.34M 199.06M 283.06M
Book Value Per Share
2.95 5.02 8.07 7.46 5.55 7.96
Common Stock
6K 6K 6K 5K 3K 3K
Retained Earnings
-859.4M -710.05M -499.75M -338.41M -215.09M -117.83M
Comprehensive Income
-15K 321K 345K -1.96M -201K -32K
Shareholders Equity
181.21M 304.08M 473.58M 313.34M 199.06M 283.06M
Total Investments
145.5M 284.54M 431.01M 297.5M 148.93M 226.01M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.